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Abstract
Background: n-3 polyunsaturated fatty acids (PUFA) have previously been demonstrated in association with a
reduced risk of chronic diseases, including insulin resistance, cancer and cardiovascular disease. In the present study,
we analyzed the effects of n-3 PUFA-rich perilla oil (PO) and fish oil (FO) high fat diet intervention against the
synthesis of hepatic high-density lipoprotein cholesterol (HDL-c) in obesity-insulin resistance model rats.
Methods: In the modeling period, the male SD rats were randomly divided into 2 groups. The rats in the high fat
(HF) group were given a high fat pure diet containing 20.62 % lard. In the intervention period, the model rats were
intervened with purified high-fat diets rich in PO or FO, containing same energy content with high fat pure diet in
HF. After the intervention, the protein and mRNA expressions status of the key genes involved in synthesis of
hepatic HDL-c were measured for further analytic comparison.
Results: The obesity-insulin resistance model rats were characterized by surprisingly high levels of serum triglyceride
(TG) and increased body weight (P < 0.05, each). After the intervention, there were no apparent changes in the serum
HDL-c and total cholesterol (TCH). In addition, the FO could up-regulate the hepatic adenosine triphosphate (ATP)
binding cassette transporter A1 (ABCA1) mRNA (P < 0.01) and protein expressions, as well as increase the level of serum
apolipoprotein A-1 (apoA-1) (P < 0.0001), and elevate the hepatic apoA-1mRNA expression (P < 0.01). Different from FO,
the PO specifically elevated the hepatic ABCA1mRNA expression (P < 0.01).
Conclusions: The FO high fat diets promoted the synthesis of HDL-c in the obesity-insulin resistance rats.
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Background
Insulin resistance (IR), characterized by the impairment of
insulin action, is an important metabolic alteration which
is frequently associated with obesity, and appears to be the
primary mediator of metabolic syndrome (MetS) [1]. Ex-
tensive research results have revealed that obesity can lead
to IR through endocrine mechanism, oxidative stress,
decreased fat oxidation capacity, and adipose tissue dys-
function [2, 3]. Obesity represents the major risk factor in
the development of insulin resistance during childhood
and adolescence [4]. With the increase in the consump-
tion of western diets with high fat content, studies have
confirmed that long-term intake of excessive amounts of
fat, especially saturated fat, is a key factor leading to insu-
lin resistance and obesity [5–7]. The obesity-insulin re-
sistance is often accompanied blood lipids disorder
and hepatic infiltration of excess free fatty acids,
which are high risk indicators for the development of
MetS, also called “syndrome X” can be defined as a
cluster of abnormalities [8–10]. Furthermore, the con-
ditions most commonly associated with low HDL-c,
the insulin-resistant metabolic syndrome, in associ-
ation with the increased catabolism of HDL and the
mechanism, are poorly understood [11]. Aside from
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the antioxidant, anti-inflammatory and antithrombotic
effects of HDL, its cardioprotective effects have been
largely attributed to its role in the reverse cholesterol
transport (RCT) pathway, in which excess cholesterol
in the peripheral tissues is returned to the liver for
utilization or elimination [12]. Although HDL pro-
motes RCT from the extrahepatic tissues to liver, the
liver itself is a major source of lipidation of nascent
HDL. It is of great importance to control not only
the blood glucose but also the lipid profile to prevent
the onset of MetS [13]. Therefore, it may be useful to
seek therapeutic drugs and therapies to ameliorate
blood lipid disorder by regulating hepatic HDL meta-
bolic pathways in insulin resistance models.
The US Food&Drug Administration (FDA) has
granted a qualified health claim for dietary n-3 PUFA
supplements: ‘Consumption of ω-3 fatty acids may
reduce the risk of coronary heart disease’ [14]. n-3
PUFA, such as a-linolenic acid[18:3(n-3), ALA], ei-
cosapentaenoic acid[20:5(n-3), EPA] and docosahexae-
noic acid[22:6(n-3), DHA], have demonstrated a wide
range of health-related benefits, including improving
heart disease related outcomes, decreasing tumour
growth and metastasis, and favourably modifying in-
sulin sensitivity [15–19]. EPA and DHA, which are
mainly ingested from fatty fish and marine animals,
have been studied extensively, whereas ALA, found in
vegetable foods, lacks substantive evidence for a bio-
logical role. The beneficial effects are influenced by
the types and quantities of n-3 PUFA, but the mecha-
nisms are less clear.
Currently, the regulation of n-3 PUFA high fat diets
on the synthesis of hepatic HDL-c in vivo has yet to be
determined. The present study mainly explores the ef-
fects of n-3 PUFA-rich PO and FO high fat diets on the
serum lipids of obesity-insulin resistance rats, as well as
the expression of the key genes involved in synthesis of
hepatic HDL-c.
Results
Diet intake and body weight in the modeling period
As illustrated in Table 1, the diet intake of the HF rats was
shown to be significantly lower than that of the normal
control (NC) group (P < 0.0001). However, the energy
intake and fat-energy intake were significantly higher than
those of the NC group (P < 0.0001, each). At the end of
the animal modeling period, the body weights of the HF
rats were significantly higher than those of the NC group
(P = 0.0186).
Insulin sensitivity
Figure 1a illustrates the fact that the levels of fasting insu-
lin (FINS) in HF were higher than those in NC (P < 0.05),
and that there was no statistical difference in fasting
serum glucose (FSG), as shown in Fig. 1b. Figure 1c illus-
trates the fact that the HF rats exhibited insulin resistance,
due to the fact that the glucose infusion rate (GIR) in the
HF was significantly lower than that of the NC in the
euglycemic-hyperinsulinemic clamp study (P = 0.0086).
Serum parameters of obesity-insulin resistance rats
Following the 14 h fasting period, the serum TG of the
rats fed with HF diet was found to be remarkably
higher than those fed with NC diet (P < 0.05), and there
was no significant difference in TCH and HDL-c, as
shown in Fig. 2a.
Serum parameters of the rats after the intervention
After an intervention, there were no apparent changes in
the serum HDL-c and TCH, as illustrated in Fig. 2b.
Analysis of the differential expressions of hepatic ABCA1
and apoA-1 by real-time quantitative PCR
The real-time qPCR results showed that, after n-3 PUFA
intervention, the expression levels of hepatic ABCA1
Table 1 Diet intake and body weight in the model construction
period
Item NC HF P
Diet consumption(g/d) 21.57±2.13 19.17±2.16 <0.0001
Energy intake(kJ/d) 345.25±33.51 373.95±41.87 <0.0001
Fat energy intake(kJ/d) 35.60±3.45 171.01±19.15 <0.0001
Weight(g) 587.75±48.77 637.43±69.28 0.0186
Fig. 1 Insulin sensitivity. a, fasting insulin; b, fasting serum glucose;
c, glucose infusion rate. Data are mean ± standard deviation (SD), in
(a) and (b) n = 8 rats per diet, in (c) n = 4 rats per group. Significance
during the HF compared to NC is indicated by * P < 0.05
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mRNA were remarkably increased (P < 0.01), and there
was no statistical difference between the PO and FO. In
contrast, the expression levels of hepatic apoA-1 mRNA in
FO were significantly higher than those in the continuous
high fat (CHF) and PO, as shown in Fig. 3a (P < 0.01, each).
Detection of serum apoA-1 by ELISA
The study results shown in Fig. 3b illustrated the fact that
the serum apoA-1 in the FO was significantly higher than
that of the CHF and PO (P < 0.0001, each), and that there
was no statistical change between the CHF and PO.
Detection of hepatic ABCA1 protein levels by Western
blotting
In order to further understand the effects of n-3 PUFA
high fat diet on obesity-insulin resistance model rats, we
investigated the effects of n-3 PUFA on key protein ex-
pressions for the synthesis of hepatic HDL-c. After the
FO intervention, the expression levels of the ABCA1
protein were dramatically increased, but there was no
apparent change in the PO intervention group, as shown
in Fig. 3c.
Discussion
In the present study, we investigated the modulatory role
of dietary n-3 PUFA high-fat diets against the synthesis
of hepatic HDL-c in obesity-insulin resistance model
rats. For the first time, it was shown that n-3 PUFA may
promote the synthesis of HDL by up-regulating the ex-
pression of key gene ABCA1. Although they share the
same effects on serum HDL-c, the FO and PO exerted
different influences on the hepatic HDL-c biosynthesis
in the obesity-insulin resistance rats.
High insulin levels resulting from an insulin resistance
lead to blood lipid abnormalities. In animal models, our
results illustrated that a high-fat diet induced insulin re-
sistance in rats with increasing serum TG. As we all
know, in the presence of insulin resistance, HDL-c levels
often are reduced [20]. But in modeling and intervention
Fig. 2 Serum biochemical parameters. (a) Serum biochemical
parameters of obesity-insulin resistance rats. (b), Serum biochemical
parameters of the rats after the intervention. Data are mean ± standard
deviation (SD), n = 12 Rats per diet. “*” (p < 0.05) means it is significantly
different with the NC or CHF group
Fig. 3 The effect of n-3 PUFA high fat diets on mRNA and protein expression. (a), Relative gene expression levels of hepatic ABCA1 and apoA-1;
(b), Serum apoA-1; (c), Protein expressions of hepatic ABCA1. Data are mean ± standard deviation (SD), n = 6 Rats per diet. “*” (p < 0.05) means it is
significantly different with the CHF group and “#” (p < 0.05) means it is significantly different with the PO group
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period, there are no apparent changes in the serum
HDL-c and TCH. Several epidemiological studies have
shown that HDL-c concentrations tend to increase
when the diet is rich in n-3 PUFA, Morvan et al.
firstly report that n-3 PUFA could decrease serum
HDL-c level [21, 22]. Since the anti-atherogenic prop-
erty of HDL is not simply determined by plasma
HDL-c concentrations but depends also on the prop-
erties of HDL [23], the effects of n-3 PUFA on HDL
functionality RCT need to be investigated. n-3 PUFA
has been shown to accelerate the last step of RCT in
mice, but the activity of the key protein for the syn-
thesis of HDL-c was an important determinant for
the beginning of RCT [22, 24]. Nutrient deprivation
can lead to the alteration both in vitro and in vivo,
such as cellular macromolecular composition change,
apoptosis of endothelial cell, and diminishment of in-
sulin signaling in the activation of neuronal autophagy
[25, 26]. So we keep diet energy equal between mod-
eling and intervention period. Therefore, in this study
we explored the effects of the different high fat diets
of n-3 PUFA on the expression of the key protein for
the synthesis of HDL-c.
The initial step in HDL formation involves the syn-
thesis and secretion of apoA-1 by the liver cells, and,
to a lesser extent, by the intestinal cells [27]. As the
main apolipoprotein of HDL-c, apoA-1 is secreted in
a lipid-poor form, and accounts for approximately
70 % of the lipoprotein [28]. ApoA-1 interacted with
ABCA1 mediating the efflux of cholesterol and phos-
pholipids, and participated in RCT. ApoA-1 overex-
pression promotes macrophage-specific RCT in vivo
[29]. Presently, the available data are insufficient to
assess whether the supplementation of HF diets with
n-3 PUFA, carried either by PO or FO, can make any
difference in the apoA-1 metabolic outcomes, with
the aim of preventing or treating metabolic disorders.
In our study, the serum apoA-1 and hepatic apoA-1
mRNA expressions were significantly increased in the
obesity-insulin resistance rats after the FO interven-
tion, and there was no statistical change between the
CHF and PO. This indicated that an FO high-fat diet
may promote RCT, and potentially protect the vascu-
lar fatty degeneration in the obesity-insulin resistance
rats. Different from our high-fat diet results, the usual
diets enriched with FO decreased the apoB-100/apoA-
1 ratio without a significant influence on serum
apoA-1 [30]. Therefore, the conditions of high-fat di-
ets may affect the physiological functions of FO.
Given that there were no significant changes on the
apoA-1 expression, the PO high-fat diets may not
have apoA-1 inducing beneficial effects. Moreover, the
FO compared with PO exhibited stronger beneficial
effects in increasing the level of serum apoA-1 and
up-regulating hepatic apoA-1 mRNA expression. This
may provide valuable evidence for further investiga-
tion regarding the different benefits of n-3 PUFA.
The ABCA1 is a membrane protein localized to the
non-lipid raft area of the plasma membrane, and medi-
ates the efflux of phospholipids and cholesterol of the
cells. It facilitates the translocation of phospholipids to
free apoA-1 in the plasma membrane, forms pre-β-HDL,
and initiates RCT [31]. Therefore, the ABCA1 plays a
rate limiting role in the first step of the synthesis of the
HDL and RCT processes [29]. A high expression of
ABCA1 in the macrophages accelerated the HDL syn-
thesis, enhanced the level of serum HDL-c, and acceler-
ated the RCT [32]. In in vitro studies, the ALA cannot
change the expression of the ABCA1 in foam cells, and
EPA is known to down-regulate ABCA1 in macro-
phages, which is mostly due to their different effects on
Liver X receptors (LXRs) [33, 34].There is no direct re-
sult of the n-3 PUFA-rich PO and FO high-fat diets on
the expression of hepatic ABCA1. In the present study,
the hepatic ABCA1 mRNA expressions in the n-3 PUFA
intervention groups were significantly higher than those
of the CHF. Therefore, it appears that n-3 PUFA high fat
diets may enhance the hepatic ABCA1-mediated efflux
of cholesterol and phospholipids to apoA-1 containing
nascent HDL particles in obesity-insulin resistance rats.
Consistent with our findings, the high dietary ratio of n-
6/n-3 PUFA can significantly increase the expression of
ABCA1 essential for the metabolism of HDL and RCT
[35]. n-3 PUFA may exhibit different functions in in vivo
and in vitro studies. In addition, the FO also exhibited
stronger beneficial effects than PO in up-regulating hep-
atic ABCA1 protein expressions in the obesity-insulin
resistance rats. Although they share the same effect on
serum HDL-c, the FO and PO high-fat diets exerted dif-
ferent influences on hepatic HDL-c biosynthesis in the
obesity-insulin resistance rats.
Conclusions
The n-3 PUFA-rich PO and FO high fat diets were
found to upregulate the hepatic ABCA1 mRNA expres-
sion in the obesity-insulin resistance rats. Furthermore,
although sharing the same effect on serum HDL-c, FO
and PO high fat diets exerted differently influence on
hepatic HDL-c biosynthesis in the obesity-insulin resist-
ance rats. In summary, FO high-fat diets may promote
the synthesis of HDL-c in obesity-insulin resistance rats.
Methods
Animals
In this study, 48 specific pathogen-free (SPF) male
Sprague–Dawley (SD) rats were purchased from the
Laboratory Animal Center of the Academy of Military
Medical Sciences (Beijing, China), and the certificate
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number of SCXK-(Army) 2007–004. The rats were
housed in micro-isolator cages with a light/dark cycle
of 12 h (6: 00 to 18: 00) and given free access to diet
and water. The temperature was controlled at 23 ± 1 °C,
and the relative humidity was 40 ± 5 %. All animal ex-
periments were performed in accordance with the guide
of the Institutional Animal Care and Use Committee of
Laboratory Animal Center.
Diets
The purified daily diets were formulated according to
the production of Test diet 58Y2 and 58 V8, which
were mainly composed of casein, maltodextrin, corn
starch, methionine, fat, cellulose, minerals, sucrose, and
vitamins. The NC group diet was added 2.4 % soybean
oil and 1.9 % of lard oil, with an energy content of
15.7 kJ/g, of which the protein-energy, carbohydrate-
energy, and fat-energy ratios were 20.2 %, 69.49 %,
10.31 %, respectively. Along with the addition of the
2.88 % soybean oil, HF/CHF, PO intervention, and FO
intervention groups were also added, which included
20.62 % lard, 4.12 % perilla oil + 16.50 % lard, and
4.12 % fish oil + 16.50 % lard, containing the same en-
ergy content of 19.35 kJ/g, of which the protein-energy,
carbohydrate-energy, and fat-energy ratios were 19.67 %,
34.59 %, 45.73 %, respectively. The fatty acid composi-
tions of PO and FO are listed in Table 2.
Groups
The 48 SPF male SD rats were randomly divided into 2
groups: 12 rats in the NC group, and 36 rats in the HF
group for modeling obesity-insulin resistance rats. After
the HF rats developed insulin resistance, they were
randomly divided into 3 groups: CHF group, PO inter-
vention group, and FO intervention group. After the
intervention at 4 weeks, animals were euthanasia, and
the liver tissue samples were collected for cryopreserva-
tion with liquid nitrogen.
Serum parameters
Before collecting blood, fasting was conducted on the rats
for a 14 h period (18:00 to 8:00) to ensure free access to
water. Then, centrifugation was carried out in order to
collect supernatant at 1000 × g for 10 min at 4 °C and
stored at −80 °C until analysis. TG, TCH, HDL-c, and FSG
were measured by using enzymatic and colorimetric
methods according to the kits’ instructions (Beijing BHKT
Clinical Co.,Ltd.). ELISA was employed for the determin-
ation of FINS and serum apoA-1 (Rapidbio INC).
Euglycemic-hyperinsulinemic clamp study
The rats fasted for a 14 h period in advance (18:00 to
8:00) of the experiment. After intramuscular anesthesia
was administered, cannula of the right jugular vein and
left common carotid artery was carried out. Intravenous
infusion channels and three-limb tubes were established,
of which one end was connected to the insulin pump,
and the other end was connected to the glucose injec-
tion pump. The basal blood glucose was required to be
measured continuously 3 times, with intervals of 5 min
each time after the blood glucose was stable. The infu-
sion of human insulin (Humulin R, Novo Nordisk) was
conducted at a constant rate of 4 mU · kg−1 · min−1, with
the blood glucose measurement time of 5 min for each
interval. The rate of the glucose infusion was adjusted
according to the measured blood glucose value, making
sure that there was stability in the blood glucose value
(basal blood glucose value ± 0.5) mmol/L. When 3 con-
secutive glucose values were all in the above range, the
evaluation index of the insulin sensitivity of the rats was
the average value of the GIR in 60 to 120 min.
Real time quantitative PCR
10 to 20 mg rat liver tissues was collected and put into
centrifuge tubes. RNA was extracted using a Qiagen
RNeasy mini kit and reverse transcribed to cDNA using
TAKARA RT reagent kit for production of a template
for real time qPCR. A total RNA of 1 μg was added to
the reverse transcription system of 20 μL for reaction at
Table 2 Types and levels of dietary fatty acids






Table 3 Primers for analysis of transcription level of gene expression
Gene Accession no. Primer Tm, °C Product length,bp
ABCA1 NM_178095.2 F 5′-AGAGCTAGGTCTCCCTT-3′ 56 151
R 5′-CACTGCCCCTGTAATGG-3′
apoA-1 NM_012738 F 5′-GAACAAGGACCTGGAGAATG-3′ 58 315
R 5′-CTGGCCTTGGTATGATACTC-3′
actin NM_031144.2 F 5′-CCCATCTATGAGGGTTACGC-3′ 50 150
R 5′-TTTAATGTCACGCACGATTTC-3′
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37 °C for 15 min, and 85 °C for 5 seconds. Real-time
qPCRs were performed with an IQ5 instrument and
software mainly as follows: 20 μl reaction system; 95 °C
for 30 s for the pre-degeneration; after which 95 °C for
5 s for the denaturation; and annealing and extension of
30 s for 40 cycles. A standard curve was generated for
all genes studied using serial dilutions of the primers
specified PCR products. Melt curve generation were
performed to determine the purity of the amplified
PCR products. There were three repetition sets for each
sample and each gene was expressed as number of
copies relative to those measured for β-actin within the
same RNA sample. Primers and their sequences are
summarized in Table 3 (Shanghai Ying Wei Jie Ji
Trading Co. Ltd.).
Western-blotting detection
The liver tissues were collected and frozen in liquid nitro-
gen immediately until homogenization. Then, 14,000 × g,
at 4 °C for centrifugation for 10 min. The concentration of
protein in the supernatant was measured using a BCA
protein assay kit (Beyotime, China). A 10 % sodium dode-
cyl sulfate (SDS)-polyacrylamide gels electrophoresis
experiment was then conducted, under the conditions of
the equal amount of total proteins of the 3 groups of CHF,
PO and FO. The total protein was transferred onto a poly-
vinylidene difluoride (PVDF) membrane and incubated
overnight with 5 % (w/v) nonfat dried milk, and then
probed overnight with primary antibodies against β-actin,
ABCA1 (all antibodies were purchased from Abcam
Inc.,USA) at 4 °C. After washing the membrane with
TBST, the membrane was incubated with the secondary
antibody for 1 h at room temperature. Proteins were visu-
alized using an enhanced chemiluminescence (ECL) kit in
accordance with the manufacturer’s instructions. The β-
actin western blot was performed as an internal control of
protein loading.
Statistical analysis
The experimental data was expressed as a mean ± stand-
ard deviation (x  s ). Data was entered into a database
and analyzed using SAS9.0 software, Student’s t-test, or
one-way ANOVA. Differences were considered to be sta-
tistically significant at p < 0.05.
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